# 바이오스페이스 일일 뉴스 리포트 - 2026년 01월 25일


## 주요 헤드라인

1. **Sanofi Stumbles Again in Eczema—But Plans FDA Filing for OX40 Blocker Anyway (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/sanofi-stumbles-again-in-eczema-but-plans-fda-filing-for-ox40-blocker-anyway>

2. **Sanofi Stumbles Again in Eczema—But Plans FDA Filing for OX40 Blocker Anyway (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/sanofi-stumbles-again-in-eczema-but-plans-fda-filing-for-ox40-blocker-anyway>

3. **Spending Bill Clears House, Keeping Priority Review Voucher Hopes Alive (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/rare-pediatric-disease-vouchers-pbm-reform-up-for-vote-in-house>

4. **Spending Bill Clears House, Keeping Priority Review Voucher Hopes Alive (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/rare-pediatric-disease-vouchers-pbm-reform-up-for-vote-in-house>

5. **Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/rare-disease-vouchers-caught-in-political-abyss-it-didnt-have-to-be-this-way>

6. **Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/rare-disease-vouchers-caught-in-political-abyss-it-didnt-have-to-be-this-way>

7. **China’s Corxel Nabs $287M Series D1 to Bankroll GLP-1 Pill (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/chinas-corxel-nabs-287m-series-d1-to-bankroll-glp-1-pill>


---
*2026년 01월 25일 바이오스페이스 뉴스 피드에서 생성된 리포트*